Pure Global AI
NCT06410716Recruiting

Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage

A Randomized Controlled Study Comparing Valve-regulated Pleural Drainage System to Traditional Closed Chest Tube Drainage
Peking Union Medical College HospitalClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Lung Cancer
Drug/Device/Intervention
Valve-regulated pleural drainage system
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Peking Union Medical College Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Apr 20, 2024
End date
Apr 30, 2025
Enrollment
100 participants
Primary outcome

Postoperative drainage duration

Summary

Thoracic drainage is an important adjunctive treatment following thoracic surgery, primarily
 aimed at removing postoperative blood, air, and exudate from the thoracic cavity. It helps
 maintain negative pressure in the thoracic cavity, promotes full lung expansion, and prevents
 pulmonary complications, especially atelectasis. Traditional closed thoracic drainage methods
 have many limitations. Dry valve-regulated pleural drainage system overcome these
 limitations. Preliminary studies have shown that they offer advantages such as high safety,
 ease of operation, and reduced nursing burden. The investigators plan to conduct a real-world
 randomized controlled study comparing the clinical efficacy of dry valve-regulated pleural
 drainage system with traditional water-sealed drainage systems, both of which are commonly
 used in clinical practice. The goal of this study is to provide solid evidence based on
 evidence-based medicine for the optimal practice of thoracic drainage, further optimize
 post-thoracic surgery drainage treatment protocols, enhance the quality and efficiency of
 patient care, and provide scientific evidence for the development or updating of relevant
 clinical guidelines.

ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06410716
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06410716 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking Union Medical College Hospital and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.